USD10
PODD Shares
About InsuletInsulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
USD10
PODD Shares
About InsuletInsulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$11.37B
OPEN PRICE
$162.25
LOW (1Y)
$138.79
HIGH (1Y)
$354.88
LOW (24H)
$159.01
HIGH (24H)
$165.54
VOLUME (24H)
$1.4M
6.83%
Price history
Time | Price | Change |
|---|---|---|
Today | $162.25 | |
1 Day | $159.51 | |
1 Week | $161.29 | |
1 Month | $143.28 | |
1 Year | $280.96 |
Past performance is not a reliable indicator of future results.
Discover more
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.